Issue lab

Several issues and types of legislation impact our industry. Visit our "Issue Lab" and learn more about Medicare Part B, importation, the value of medicine and more!

Critics argue that the importation of unapproved medicines would help save consumers money. What proponents of importation often miss is the critical issue of safety and how this would impact access to new, innovative treatments. 

Medicare Part B, commonly referred to as Medicare’s medical benefit, covers a wide range of health care services for seniors and people living with disabilities. Part B covers physician office visits, outpatient care, ambulance services, some medical devices and most medicines administered by a physician. Medicines covered by Part B include treatments for complex conditions like cancer, rheumatoid arthritis, autoimmune conditions and more.

Since 2000, biopharmaceutical companies have brought more than 500 new medicines to patients in the U.S. As a result, we have successfully improved the quality and length of life for Americans confronting the most costly and challenging diseases (cancer, diabetes, etc.).

Biologics are complex medicines manufactured using living cells and tissues. America’s biopharmaceutical research companies are using biological processes testing 907 medicines and vaccines targeting more than 100 diseases. In order to realize the full potential of biologics, it is essential that the U.S. maintain policy and regulatory environments that help foster the discovery and development processes.

Medicare Part D is the government program that provides seniors and people with disabilities with access to affordable prescription drug coverage. Through market-based competition, Part D allows beneficiaries to choose from a range of private plans that best meet their needs. Today, 90% of Medicare beneficiaries have comprehensive prescription drug coverage, and a majority receives their coverage through Part D.

Medicare Part D is a uniquely popular and successful program that provides over 42 million seniors and individuals with disabilities access to a range of affordable prescription drug plans. Its unique structure keeps costs down by providing a market of options and offering patients the freedom to choose among dozens of private health plans competing for patient enrollment based on premiums, coverage, quality and service.

Clinical trials are carefully controlled tests of new medicines designed to evaluate their safety and effectiveness and compile the evidence needed by the U.S. Food and Drug Administration and other regulators around the world to approve new treatments.

America's biopharmaceutical industry relies on dedicated researchers and workers to produce lifesaving treatments. The industry also relies on strong intellectual property laws, like patents.